Home Mission Technologies scIMs Pipeline Team

An AAV Research and Development Gene Therapy Company

Our Mission:

To improve vision and life quality by adapting natural mechanisms using safe and single dose therapeutics.

Technologies

Human-Tropic and Antibody Evading AAV Capsids

PMID: 3263745

scIMs

Single Chain Immune Modulators

PMID: 39245940


Bedrock’s Current Gene Therapy Pipeline

Our Team

House

Jackie Bower

PhD

House

Brian Gilger

DVM MS DACVO

House

Matthew Hirsch

PhD

House

Chengwen Li

MD PhD

House

Roger “Bryan” Sutton

PhD

Contact us at: info@bedrocktherapeutics.com

To the top